Key result
Hammerhead ribozymes targeted against the polymerase gene of mouse hepatitis virus significantly reduced the production of infectious progeny virus particles in transfected cell lines.
Hammerhead ribozymes targeted against the MHV polymerase gene significantly reduce viral multiplication in vitro.
In vitro antiviral activity against MHV; hypothesis-generating for ribozyme antivirals and requires in vivo validation before further development.
We designed and constructed two hammerhead ribozymes targeted against the polymerase gene of mouse hepatitis virus (MHV). They consisted of a 22-nucleotide (nt) ribozyme core sequence and antisense sequences of different lengths, 243-nt (S-ribozyme) and 926-nt (L-ribozyme). In cell-free reactions, the constructed ribozymes cleaved the target RNA at a specific site. Vectors that directed the expression of ribozymes by a promoter of human elongation factor 1 alpha were introduced into DBT cells, and the resulting several cell lines constitutively expressing the ribozymes were selected by Northern blot analysis and examined for intracellular multiplication of MHV. The production of infectious progeny virus particles was significantly reduced in the transfected cell lines expressing either S-ribozyme or L-ribozyme. Although the in vitro cleavage process of L-ribozyme was slower than that of S-ribozyme, no difference was observed in inhibitory effects on MHV multiplication between S- and L-ribozymes in the transfected cells.
No takes yet. Share an insight, caveat, or question.
Maeda et al. (1994) studied Mouse hepatitis virus (MHV) infection. Hammerhead ribozymes targeted against the polymerase gene of MHV was evaluated on Production of infectious progeny virus particles. Hammerhead ribozymes targeted against the polymerase gene of mouse hepatitis virus significantly reduced the production of infectious progeny virus particles in transfected cell lines.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: